Journal profile · Pharmacology, Toxicology and Pharmaceutics-General Pharmacology, Toxicology and Pharmaceutics

Infarma Pharmaceutical Sciences

ISSN 0104-0219 · eISSN 2526-2858 · Federal Council of Pharmacy · Brazil

Infarma Pharmaceutical Sciences: diamond open access (no APC); no APC; review about 10 weeks (community reports); 11 articles in 2025; indexed in Scopus.

Impact factor—No published value

CAS zone—Not in the CAS Journal Ranking

CiteScore quartileQ4General Pharmacology, Toxicology and Pharmaceutics · rank 79/79 · 0th percentile

Review timeabout 10 weeksCommunity average

APCNo APCDiamond open access (no APC)

Acceptance—No reports yet

Articles per year112025 · OpenAlex count

Scope

Aims, scope and focus

Infarma Pharmaceutical Sciences is published by Federal Council of Pharmacy. By OpenAlex counts of its recent articles, its largest topics are Pharmacy and Medical Practices, Phytochemistry Medicinal Plant Applications and Pharmaceutical Practices and Patient Outcomes, together about 44.2% of its articles. (generated from OpenAlex topic counts and CAS ranking data)

Publicação anual do Conselho Federal de Farmácia (CFF) que traz o relato de experiências de sucesso de farmacêuticos que atuam na atenção básica, especializada e hospitalar do SUS.

From the journal's Aims & Scope

Research area (LetPub): Pharmacology, Toxicology and Pharmaceutics-General Pharmacology, Toxicology and Pharmaceutics

Main research topics OpenAlex counts of recent articles; shares are approximate

Pharmacy and Medical PracticesPharmacology, Toxicology and Pharmaceutics22.6%
Phytochemistry Medicinal Plant ApplicationsAgricultural and Biological Sciences11.7%
Pharmaceutical Practices and Patient OutcomesMedicine9.9%
Public Health in BrazilSocial Sciences7.3%
Analytical Methods in PharmaceuticalsChemistry5.1%
Pharmaceutical Quality and CounterfeitingMedicine4.2%
Complementary and Alternative Medicine StudiesMedicine4.2%
Pharmaceutical studies and practicesMedicine4%

Rankings & indexing

CAS ranking and database indexing

CAS Journal Ranking

CAS Journal Ranking, upgraded edition (March 2025)Not covered

Not covered by this edition.

CAS Xinrui Journal Ranking (March 2026)Not covered

Not covered by this edition.

CAS Journal Ranking, previous upgraded edition (December 2023)Not covered

Not covered by this edition.

CiteScore quartiles (Scopus, June 2026 release)

Subject	Quartile	Rank	Percentile
General Pharmacology, Toxicology and Pharmaceutics	Q4	79/79	0th

Scopus ranks journals by CiteScore within each subject: the 75th percentile and above is Q1, then a quartile every 25 points. A different system from the CAS zones.LetPub

Database indexing

ScopusDOAJLetPub

International journal early-warning lists: not listed in any editionLetPub

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Metrics

Impact metrics and publication volume

Impact

CiteScore 2026-06: 0.1LetPub · 2026-11-01
SJR 2026-06: 0.11LetPub · 2026-11-01
SNIP 2026-06: 0.02LetPub · 2026-11-01
h-index: 14OpenAlex · 2026-11-01
i10-index: 24OpenAlex · 2026-11-01
2-year mean citedness: 0.12OpenAlex · 2026-11-01
Share of gold OA articles: 0%LetPub · 2026-11-01

Articles by year OpenAlex count · 1,036 in total · the current year is incomplete

Year	Articles	Open access	Citations
2026	27	27	42
2025	11	11	72
2024	13	13	127
2023	31	31	147
2022	34	34	162
2021	38	38	205

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Review & acceptance

Review time and acceptance

Average review time (community reports): about 10 weeksLetPub · 2026-11-01

Submission to publication (journal-reported): about 10 weeksDOAJ · 2026-11-01
Peer review: Double anonymous peer reviewDOAJ

Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.

Fees & open access

APC and open-access policy

Diamond open access (no APC)DOAJ

Every article is open access and authors pay no article processing charge.

Source	APC	Fee waiver	License	Observed
DOAJ	No APC	No	CC BY-NC-ND	2026-11-01
LetPub	No APC	No	—	2026-11-01

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Profile

Publication details and official links

Publisher: Federal Council of Pharmacy
Country or region: Brazil
Language: English, Spanish, Portuguese
ISSN: 0104-0219
Print ISSN: 2526-2866
Electronic ISSN: 2526-2858
Official links: Journal homepage ↗DOAJ
Author guidelines ↗LetPub
Aims & Scope ↗LetPub
APC information ↗DOAJ
Open access statement ↗DOAJ
License & copyright ↗DOAJ
Peer review process ↗LetPub
Editorial board ↗LetPub

FAQ

Frequently asked questions about Infarma Pharmaceutical Sciences

How long does peer review take at Infarma Pharmaceutical Sciences?

Authors report an average review time of about 10 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.

Which databases index Infarma Pharmaceutical Sciences?

According to LetPub and DOAJ records, Infarma Pharmaceutical Sciences is indexed in Scopus and DOAJ.

Is Infarma Pharmaceutical Sciences open access, and what is the APC?

Infarma Pharmaceutical Sciences is a diamond open-access journal (no APC). It charges no article processing charge.

Sources and updates

The facts on this page come from LetPub, OpenAlex, DOAJ, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: 2026-11-01.